Texas Daily Standard: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Texas Daily Standard.

Press releases published on August 20, 2026

Sysco Declares Quarterly Dividend Payment
Quanex Building Products Announces Third Quarter 2026 Earnings Release and Conference Call Schedule
Asure Software Sets August & September 2026 Investor Conference Schedule
Azoteq Appoints Johnson Company, Inc. as Sales Representative for the U.S. Midwest
Meritage Homes Announces Quarterly Cash Dividend
QMS2GO to Exhibit at IADC ART 2026, Bringing Digital Supplier Development to the Drilling Industry
Legacy Health Works Expands On-Site and Virtual Training for Healthcare Teams
Michelle May O'Neil Earns Best Lawyers in America 2027 Recognition for Excellence in Both Appellate Practice and Family Law for the Eleventh Straight Year
Free Car Wash Days to Celebrate Upgrades at ZIPS Car Wash
Nearly 70,000 Austin ISD Students Return to School as Drivers Adjust to Back-to-School Traffic
DAZED INC. ACCELERATES GROWTH INITIATIVES: REACHES 13 LOCATIONS WITH DALLAS EXPANSION, ANNOUNCES Q4 STOCK BUYBACK, AND REPORTS STRONG Q2 2026 FINANCIALS
KUNGFU.AI Bolsters Leadership Team with CMO and CRO Appointments to Scale Client Impact
SpyCloud Turns 10: A Decade of Data Built the Sharpest View Yet of Identity Threats
Calling All Gossip Gourds: Pumpkin Spice Returns as Part of Buff City Soap's New Five-Fragrance Fall Collection
Skyward Group Announces CFO Transition Effective March 31, 2027
Nightfood Holdings Inc. (OTCQB: NGTF) Moves Beyond Proving Out Tech to Actual Deployment with LOI Announcement
Sysco Announces Strategic Board Appointments and AI Transformation Initiatives Intended to Accelerate Growth, Long-Term Value Creation
Westwood to Launch Westwood Salient Enhanced Power & Infrastructure ETF (PWRX) as the First New ETF on the Texas Stock Exchange
Rein Therapeutics Receives U.S. FDA Fast Track Designation for LTI-03 in Idiopathic Pulmonary Fibrosis
Cerenome Highlights Presentations at the 2026 SNO/ASCO CNS Metastases Conference Demonstrating Progress in Both Therapeutics and Diagnostics Business Lines

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Texas Daily Standard

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.